Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CE-224535 (PF-04905428) is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 49,000 |
5 mg | 在庫あり | ¥ 123,500 |
10 mg | 在庫あり | ¥ 178,000 |
25 mg | 在庫あり | ¥ 273,500 |
50 mg | 在庫あり | ¥ 365,000 |
100 mg | 在庫あり | ¥ 498,000 |
500 mg | 在庫あり | ¥ 998,500 |
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 95,000 |
説明 | CE-224535 (PF-04905428) is a selective antagonist of P2X7 receptor. CE-224535 can be used in disease-modifying antirheumatic studies. |
別名 | PF-04905428 |
分子量 | 480.94 |
分子式 | C22H29ClN4O6 |
CAS No. | 724424-43-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 95 mg/mL (197.53 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CE-224535 724424-43-5 Membrane transporter/Ion channel Neuroscience P2X Receptor inhibit PF-04905428 P2XRs Inhibitor PF04905428 PF 04905428 CE 224535 CE224535 inhibitor